Pembrolizumab-induced antiTTG IgA-negative duodenitis treated with gluten withdrawal

Eur J Gastroenterol Hepatol. 2021 Aug 1;33(8):1130-1131. doi: 10.1097/MEG.0000000000002077.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized* / adverse effects
  • Celiac Disease*
  • Duodenitis* / chemically induced
  • Duodenitis* / diagnosis
  • Duodenitis* / drug therapy
  • Gliadin
  • Glutens
  • Humans
  • Immunoglobulin A
  • Male
  • Middle Aged

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunoglobulin A
  • Glutens
  • Gliadin
  • pembrolizumab